
Pulmonary Endarterectomy (PEA) emerges as the top treatment for chronic thromboembolic pulmonary hypertension, benefiting patients with accessible lesions in the pulmonary vasculature. While PEA boasts a low in-hospital mortality rate (<5%), meticulous perioperative management remains crucial to prevent complications. Reperfusion pulmonary edema, airway hemorrhage, and right ventricular failure are major challenges, requiring extracorporeal membrane oxygenation for recovery. Successful PEA significantly improves survival (over 70% at 10 years).
Like
Save
Share